Rights and permissions
About this article
Cite this article
Dolasetron less costly than ondansetron in PONV. Pharmacoecon. Outcomes News 473, 8 (2005). https://doi.org/10.2165/00151234-200504730-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504730-00021